New Hampshire 2026 Session Status: Introduced 4 R cosponsors

SB256 — (New Title) establishing safety and care requirements for clinician-administered drugs.

Last action — INTERIM STUDY

  1. 1
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill has been introduced in the Senate. Introduced January 23, 2025. It must pass committee before a floor vote.

Next likely step: a committee referral and hearing.

Odds of enactment

Low chance

Based on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Not enough signal yet

Not enough signal yet to read this bill's trajectory — we surface a likelihood only once there's real movement (stage, sponsorship, committee, or votes) to point to.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

Summary

(New Title) establishing safety and care requirements for clinician-administered drugs.

Bill Text

How this bill changes current law

1 change Share ↗

AI-generated reading aid from the bill's amendatory text — verify against the official bill.

This bill adds new requirements for health maintenance organizations regarding the dispensing of clinician-administered drugs.

  • RSA 420-B

    420-B:27 Dispensing of Clinician-Administered Drugs. I. As used in this section, "clinician-administered drug" means an outpatient prescription drug other than a vaccine that: (a) Cannot reasonably be self-administered by the patient to whom the drug is prescribed or by a non-clinician individual assisting the patient with the self-administration; and (b) Is typically administered: (1) By a health care professional authorized under the laws of this state to administer the drug, including when acting under a physician’s delegation and supervision; and (2) In a physician’s office, hospital outpatient infusion center, or other clinical setting. II. A health maintenance organization or a third party acting on its behalf shall not refuse to authorize, approve, or pay a provider for a covered clinician-administered drug that was dispensed by any in-network hospital or clinic, provided that: (a) According to medical standards of care for the patient’s condition, the medication must be provided to the patient more expeditiously than the medication could be provided via any other channel covered by the insurer; and (b) The dispensing and any associated authorization, approval, or payment occurs consistent with the terms and conditions of similarly situated network participants and according to the benefit offered by the health maintenance organization. III. Unless otherwise requested in writing by the patient or prescriber, a health maintenance organization, pharmacy benefits manager, or other third party acting on behalf of the health maintenance organization, shall not, by contract, written policy, or written procedure, require that a pharmacy dispense a clinician-administered drug directly to a patient with the expectation or intention that the patient will transport the medication to a health care setting for administration by a health care professional.

    This establishes new definitions and prohibitions for health maintenance organizations regarding the dispensing of clinician-administered drugs.

Amendments

2 amendments

Click Show changes on an amendment above to see how it modifies the bill.

Action History

  1. Executive Session: 10/14/2026 10:00 am GP 229

  2. Subcommittee Work Session: 10/07/2026 10:00 am GP 229

  3. Subcommittee Work Session: 09/09/2026 10:00 am GP 229

  4. Refer for Interim Study: MA VV 05/14/2026 HJ 13 P. 2

  5. Committee Report: Refer for Interim Study 04/29/2026 (Vote 15-0; CC) HC 19 P. 6

  6. Executive Session: 04/29/2026 10:00 am GP 229

  7. Subcommittee Work Session: 04/22/2026 10:00 am GP 229

  8. Public Hearing: 04/07/2026 02:15 pm GP 159

  9. Subcommittee Work Session: 04/08/2026 10:00 am GP 229

  10. Vacated and Referred to Commerce and Consumer Affairs (Rep. Kofalt): MA VV (in recess of) 02/19/2026 HJ 5 P. 127

  11. Introduced (in recess of) 02/19/2026 and referred to Health, Human Services and Elderly Affairs HJ 5 P. 124

  12. Ought to Pass with Amendment #2025-3029s, MA, VV; OT3rdg; 01/07/2026; SJ 1

  13. Committee Amendment # 2025-3029s, AA, VV; 01/07/2026; SJ 1

  14. Committee Report: Ought to Pass with Amendment # 2025-3029s, 01/07/2026; Vote 5-0; CC; SC 46

  15. Rereferred to Committee, MA, VV; 03/06/2025; SJ 6

  16. Committee Report: Rereferred to Committee, 03/06/2025; Vote 5-0; CC; SC 11

  17. Hearing: 02/12/2025, Room 101, LOB, 09:15 am; SC 9

  18. Introduced 01/09/2025 and Referred to Health and Human Services; SJ 3

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 4 co-sponsors · 410 not signed on

Sponsors (1)

Co-sponsors (4)

Not signed on (410)

410 members have not signed on to this bill.

Show all 410 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

public-safety healthcare
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does SB256 do?
(New Title) establishing safety and care requirements for clinician-administered drugs.
Who sponsors SB256?
SB256 is sponsored by Tim McGough (Republican), David Rochefort (Republican), Julie Miles (Republican), Bill Gannon (Republican), and John Michael Potucek.
What is the current status of SB256?
This bill has been introduced in the Senate. Introduced January 23, 2025. It must pass committee before a floor vote.
Where can I track SB256?
Track SB256 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB256

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of SB256

Last checked for changes 7 days ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →